
Robert Stockton Jones Jr.
Examiner (ID: 3854)
| Most Active Art Unit | 1762 |
| Art Unit(s) | 1796, 1762 |
| Total Applications | 1302 |
| Issued Applications | 945 |
| Pending Applications | 17 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 823727
[patent_doc_number] => 07405208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-29
[patent_title] => 'Benzoquinone ansamycins'
[patent_app_type] => utility
[patent_app_number] => 11/056470
[patent_app_country] => US
[patent_app_date] => 2005-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15988
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/405/07405208.pdf
[firstpage_image] =>[orig_patent_app_number] => 11056470
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/056470 | Benzoquinone ansamycins | Feb 10, 2005 | Issued |
Array
(
[id] => 168630
[patent_doc_number] => 07666913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Method of treating or preventing osteoporosis using isotaxiresinol derived from Taxus yunnanensis'
[patent_app_type] => utility
[patent_app_number] => 10/570252
[patent_app_country] => US
[patent_app_date] => 2005-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3599
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/666/07666913.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570252
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570252 | Method of treating or preventing osteoporosis using isotaxiresinol derived from Taxus yunnanensis | Jan 26, 2005 | Issued |
Array
(
[id] => 4959768
[patent_doc_number] => 20080274193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Retinoic Acid-Containing Antidiabetic Agent'
[patent_app_type] => utility
[patent_app_number] => 10/586775
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4377
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586775
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586775 | Retinoic Acid-Containing Antidiabetic Agent | Jan 20, 2005 | Abandoned |
Array
(
[id] => 7181156
[patent_doc_number] => 20050124663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/036842
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18836
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124663.pdf
[firstpage_image] =>[orig_patent_app_number] => 11036842
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/036842 | Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes | Jan 13, 2005 | Abandoned |
Array
(
[id] => 4950000
[patent_doc_number] => 20080306126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Peroxisome proliferator activated receptor treatment of hyperhomocysteinemia and its complications'
[patent_app_type] => utility
[patent_app_number] => 11/029048
[patent_app_country] => US
[patent_app_date] => 2005-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3411
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306126.pdf
[firstpage_image] =>[orig_patent_app_number] => 11029048
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/029048 | Peroxisome proliferator activated receptor treatment of hyperhomocysteinemia and its complications | Jan 3, 2005 | Abandoned |
Array
(
[id] => 6913024
[patent_doc_number] => 20050176782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Medicament and method for treating vulodynia'
[patent_app_type] => utility
[patent_app_number] => 11/027022
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1051
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176782.pdf
[firstpage_image] =>[orig_patent_app_number] => 11027022
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/027022 | Medicament and method for treating vulodynia | Dec 29, 2004 | Abandoned |
Array
(
[id] => 380131
[patent_doc_number] => 07309706
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-18
[patent_title] => 'Method for the treatment of diseases requiring inhibition or a reduction in the activity of pH value-regulating bicarbonate transporter proteins'
[patent_app_type] => utility
[patent_app_number] => 11/013326
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8026
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/309/07309706.pdf
[firstpage_image] =>[orig_patent_app_number] => 11013326
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/013326 | Method for the treatment of diseases requiring inhibition or a reduction in the activity of pH value-regulating bicarbonate transporter proteins | Dec 16, 2004 | Issued |
Array
(
[id] => 6939868
[patent_doc_number] => 20050113431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Method of treating isolated systolic hypertension'
[patent_app_type] => utility
[patent_app_number] => 11/012041
[patent_app_country] => US
[patent_app_date] => 2004-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1790
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113431.pdf
[firstpage_image] =>[orig_patent_app_number] => 11012041
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/012041 | Method of treating isolated systolic hypertension | Dec 13, 2004 | Abandoned |
Array
(
[id] => 141976
[patent_doc_number] => 07687476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-30
[patent_title] => 'Specific inhibitors of acute and chronic inflammation'
[patent_app_type] => utility
[patent_app_number] => 10/994663
[patent_app_country] => US
[patent_app_date] => 2004-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 2589
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/687/07687476.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994663 | Specific inhibitors of acute and chronic inflammation | Nov 21, 2004 | Issued |
Array
(
[id] => 7010282
[patent_doc_number] => 20050063998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Oral solution containing galantamine and a sweetening agent'
[patent_app_type] => utility
[patent_app_number] => 10/980970
[patent_app_country] => US
[patent_app_date] => 2004-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2422
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20050063998.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980970
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980970 | Oral solution containing galantamine and a sweetening agent | Nov 3, 2004 | Abandoned |
Array
(
[id] => 6939769
[patent_doc_number] => 20050113332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Compositions and methods for treating an arthritic condition'
[patent_app_type] => utility
[patent_app_number] => 10/980364
[patent_app_country] => US
[patent_app_date] => 2004-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4946
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113332.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980364 | Compositions and methods for treating an arthritic condition | Nov 1, 2004 | Abandoned |
Array
(
[id] => 7217367
[patent_doc_number] => 20050054735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => '6-Methoxy-2-naphthylacetic acid prodrugs'
[patent_app_type] => utility
[patent_app_number] => 10/970571
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2894
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054735.pdf
[firstpage_image] =>[orig_patent_app_number] => 10970571
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/970571 | 6-Methoxy-2-naphthylacetic acid prodrugs | Oct 20, 2004 | Abandoned |
Array
(
[id] => 6939872
[patent_doc_number] => 20050113435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Histamine-3 receptor ligands for diabetic conditions'
[patent_app_type] => utility
[patent_app_number] => 10/959799
[patent_app_country] => US
[patent_app_date] => 2004-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12994
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113435.pdf
[firstpage_image] =>[orig_patent_app_number] => 10959799
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/959799 | Histamine-3 receptor ligands for diabetic conditions | Oct 5, 2004 | Abandoned |
Array
(
[id] => 6972307
[patent_doc_number] => 20050038017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Method and composition for restoring diuretic and renal function'
[patent_app_type] => utility
[patent_app_number] => 10/953981
[patent_app_country] => US
[patent_app_date] => 2004-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7085
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20050038017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10953981
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/953981 | Method and composition for restoring diuretic and renal function | Sep 28, 2004 | Abandoned |
Array
(
[id] => 7034296
[patent_doc_number] => 20050032806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Method for treating anhedonia using dopamine agonists'
[patent_app_type] => utility
[patent_app_number] => 10/941524
[patent_app_country] => US
[patent_app_date] => 2004-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1654
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10941524
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/941524 | Method for treating anhedonia using dopamine agonists | Sep 14, 2004 | Abandoned |
Array
(
[id] => 7051334
[patent_doc_number] => 20050187221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Method of treating ischemia reperfusion injury'
[patent_app_type] => utility
[patent_app_number] => 10/935466
[patent_app_country] => US
[patent_app_date] => 2004-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9735
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187221.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935466
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935466 | Method of treating ischemia reperfusion injury | Sep 6, 2004 | Abandoned |
Array
(
[id] => 5643339
[patent_doc_number] => 20060281794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Erg channel openers for the treatment of cardiac arrhythmias'
[patent_app_type] => utility
[patent_app_number] => 10/570250
[patent_app_country] => US
[patent_app_date] => 2004-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14575
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281794.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570250
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570250 | ERG channel openers for the treatment of cardiac arrhythmias | Sep 5, 2004 | Issued |
Array
(
[id] => 7098589
[patent_doc_number] => 20050131048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Enhancement of bone growth and inhibition of bone resorption'
[patent_app_type] => utility
[patent_app_number] => 10/932323
[patent_app_country] => US
[patent_app_date] => 2004-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5702
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20050131048.pdf
[firstpage_image] =>[orig_patent_app_number] => 10932323
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/932323 | Method of increasing bone density or treating osteoporosis | Aug 31, 2004 | Issued |
Array
(
[id] => 7436121
[patent_doc_number] => 20040266851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors'
[patent_app_type] => new
[patent_app_number] => 10/489807
[patent_app_country] => US
[patent_app_date] => 2004-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9213
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266851.pdf
[firstpage_image] =>[orig_patent_app_number] => 10489807
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/489807 | Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors | Aug 29, 2004 | Abandoned |
Array
(
[id] => 6918835
[patent_doc_number] => 20050096396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning'
[patent_app_type] => utility
[patent_app_number] => 10/924591
[patent_app_country] => US
[patent_app_date] => 2004-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15014
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096396.pdf
[firstpage_image] =>[orig_patent_app_number] => 10924591
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/924591 | Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning | Aug 23, 2004 | Abandoned |